arrow
M

Michelle Klein

Netherlands Cancer Institute
H指数:12
被引数:2,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

REPURPOSING DRUGS IN RESEARCH AND CANCER CLINICAL TRIALS (REDIRECCT); PHASE 0 PITAVASTATIN IN GLIOBLASTOMA PATIENTS.

药物重定位在研究和癌症临床试验中的应用(REDIRECCT);用于胶质母细胞瘤患者的Phase 0匹伐他汀。

2025-10-010
OAAI
Kosoltanapiwat et al. A Novel Simian Adenovirus Associating with Human Adenovirus Species G Isolated from Long-Tailed Macaque Feces. ( vol 15, 1371 , 2023)
2023-09-040
OAAI
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
2023-08-2410
OA
Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness
2021-04-2746
OAAI
Seasonal coronavirus protective immunity is short-lasting
2020-09-14453
OAAI
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

食管腺癌中基质来源的白细胞介素6驱动上皮-间质转化和治疗抵抗

2019-01-22133
OAAI
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
2019-01-010
OAAI